MRNA Vaccine Access Carves Up World Into Haves and Have-Nots bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
May 19, 2021
India’s messy vaccination strategy, unlike any other in the world, is now pitting its own states against each other.
After the Narendra Modi government announced a “liberalised” policy on April 19, Indian states can now directly buy Covid-19 vaccines from manufacturers. In the face of an acute shortage of doses of Covisheild and Covaxin, the two India-made vaccines currently approved for emergency use, some state governments have now floated “global tenders” shots.
States like Maharashtra, Uttar Pradesh, Rajasthan, and Kerala are trying to directly buy vaccines from international vaccine makers, in the hope that these shots would be given a fast-tracked approval in India.
Synopsis
Many manufacturers, including Serum, already have missed timelines and commitments, Poonawalla said in an interview. It will take two to three months for shipments to Covax to really pick up, and reaching the 2021 target of 2 billion doses will be challenging, he said, predicting it will “spill over by a few months.”
Reuters
Poonawalla’s comments highlight the continuing challenge of vaccine inequality that threatens to prolong the pandemic after richer nations raced to stockpile supplies.
Vaccine nationalism in countries including the U.S. and India is likely to derail efforts by the World Health Organization to deliver 2 billion doses to poorer and middle-income nations by the end of the year, according to the head of the world’s biggest vaccine maker.
US to provide financial assistance to Indian vaccine maker Biological E
The Quad leaders decided to launch a mega vaccine initiative under which coronavirus vaccines will be produced in India for the Indo-Pacific region with financial assistance from the US and Japan, while Australia will contribute in logistical aspects.Premium
2 min read
. Updated: 13 Mar 2021, 08:45 AM IST PTI
US will work with Biological E Ltd to finance increased capacity to support production of at least 1 billion doses of COVID-19 vaccines by the end of 2022
Share Via
Read Full Story
NEW DELHI :
The US will provide financial assistance to support Indian drug-maker Biological E s effort to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022, a document released by the White House on Friday after the Quad summit said.
Pfizer dan BioNTech Mulai Uji Coba Vaksin Covid-19 untuk Ibu Hamil bisnis.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bisnis.com Daily Mail and Mail on Sunday newspapers.